These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 10902748)

  • 1. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis.
    Plant MJ; Williams AL; O'Sullivan MM; Lewis PA; Coles EC; Jessop JD
    Arthritis Rheum; 2000 Jul; 43(7):1473-7. PubMed ID: 10902748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study.
    Markatseli TE; Voulgari PV; Alamanos Y; Drosos AA
    J Rheumatol; 2011 Jan; 38(1):44-52. PubMed ID: 20952476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
    Korpela M; Laasonen L; Hannonen P; Kautiainen H; Leirisalo-Repo M; Hakala M; Paimela L; Blåfield H; Puolakka K; Möttönen T;
    Arthritis Rheum; 2004 Jul; 50(7):2072-81. PubMed ID: 15248204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The course of radiologic damage during the first six years of rheumatoid arthritis.
    Hulsmans HM; Jacobs JW; van der Heijde DM; van Albada-Kuipers GA; Schenk Y; Bijlsma JW
    Arthritis Rheum; 2000 Sep; 43(9):1927-40. PubMed ID: 11014342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.
    Machold KP; Stamm TA; Nell VP; Pflugbeil S; Aletaha D; Steiner G; Uffmann M; Smolen JS
    Rheumatology (Oxford); 2007 Feb; 46(2):342-9. PubMed ID: 16899498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.
    Bakker MF; Jacobs JW; Kruize AA; van der Veen MJ; van Booma-Frankfort C; Vreugdenhil SA; Bijlsma JW; Lafeber FP; Welsing PM
    Ann Rheum Dis; 2012 Jun; 71(6):830-5. PubMed ID: 22128075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system.
    van Leeuwen MA; van Rijswijk MH; Sluiter WJ; van Riel PL; Kuper IH; van de Putte LB; Pepys MB; Limburg PC
    J Rheumatol; 1997 Jan; 24(1):20-7. PubMed ID: 9002006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
    Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
    J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis.
    Matsuda Y; Yamanaka H; Higami K; Kashiwazaki S
    J Rheumatol; 1998 Mar; 25(3):427-32. PubMed ID: 9517758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint.
    Meeuwisse CM; van der Linden MP; Rullmann TA; Allaart CF; Nelissen R; Huizinga TW; Garritsen A; Toes RE; van Schaik R; van der Helm-van Mil AH
    Arthritis Rheum; 2011 May; 63(5):1265-73. PubMed ID: 21305530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group.
    Listing J; Rau R; Müller B; Alten R; Gromnica-Ihle E; Hagemann D; Zink A
    J Rheumatol; 2000 Sep; 27(9):2100-9. PubMed ID: 10990219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome.
    Knudsen LS; Klarlund M; Skjødt H; Jensen T; Ostergaard M; Jensen KE; Hansen MS; Hetland ML; Nielsen HJ; Johansen JS
    J Rheumatol; 2008 Jul; 35(7):1277-87. PubMed ID: 18597410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.
    Machold KP; Stamm TA; Eberl GJ; Nell VK; Dunky A; Uffmann M; Smolen JS
    J Rheumatol; 2002 Nov; 29(11):2278-87. PubMed ID: 12415582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years.
    Rau R; Herborn G; Zueger S; Fenner H
    J Rheumatol; 2000 Nov; 27(11):2566-75. PubMed ID: 11093435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between time-integrated disease activity estimated by DAS28-CRP and radiographic progression of anatomical damage in patients with early rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Filippucci E; Grassi W
    BMC Musculoskelet Disord; 2011 May; 12():120. PubMed ID: 21624120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal.
    Paulus HE; Oh M; Sharp JT; Gold RH; Wong WK; Park GS; Bulpitt KJ;
    Arthritis Rheum; 2004 Apr; 50(4):1083-96. PubMed ID: 15077290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of a ceiling effect on the assessment of radiographic progression in rheumatoid arthritis during the first 6 years of disease.
    Kuper IH; van Leeuwen MA; van Riel PL; Sluiter WJ; Houtman NM; Cats HA; van Rijswijk MH
    J Rheumatol; 1999 Feb; 26(2):268-76. PubMed ID: 9972957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.
    Hammer HB; Odegard S; Fagerhol MK; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
    Ann Rheum Dis; 2007 Aug; 66(8):1093-7. PubMed ID: 17234650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.